Quarterly report · Q2
4539.TEDINET S100S7O5
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥298m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥167m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥10m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥58m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥752m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥27m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥31m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥339m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥31m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥896m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥50.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥48.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥50.7bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥592m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥916m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥351m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥394m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥148m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥8.72 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.31 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.07 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥248.43 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.51 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥546m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥544m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥5m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥355m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | −¥298m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥439m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥16m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥15.8bn |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| jpcrp040300-q2r_E00957-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥183m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥167m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 543
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 714000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1955 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 242000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0662 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 144000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0394 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 132000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0362 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 126000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0345 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 123000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0337 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 121000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0332 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 108000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0295 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 104000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0286 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 78000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0214 | |
| Number of shares held | CurrentQuarterInstant | 1894000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.5186 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 609200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3620200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 36202 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 32020 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 4261420 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 36202 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 609200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 609200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1429 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 609200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 609200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1429 | |
| Cash and deposits | Prior1YearInstant | 10529000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 11321000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 7516000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 6873000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 3738000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 3968000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 6468000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 6893000000 | JPY |
| Work in process | Prior1YearInstant | 1277000000 | JPY |
| Work in process | CurrentQuarterInstant | 1564000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |